Data: 9 May 2026

Louise Tofts

NSW, Australia · RMSANZ Member (Ordinary Membership) · FAFRM

Institution(s): AU

MM 1 - Metropolitan(Postcode: 2109)

Paediatric rehabilitationGenetics and molecular biologyExercise and physical activityMusculoskeletal rehabilitationResearch methods and evaluation
16
H-index
55
Publications
1,197
Citations
3.45
FWCI
26
Funding Awards
2
Clinical Trials
Publication Timeline

Click a bar to filter publications by year

19982009201320142015201620172019202020212022202320242025036912
Co-Author Network
2 collaborators · Node size = shared publications
CollaboratorShared PubsProfile
Adrienne Epps2View
Katherine Langdon2View
Clinical Trials (2)

The Clinical Characteristics of Children with Generalised Joint Hypermobility and thier Relationship to Adverse Outcomes

ACTRN12610000054011Unknown

A Randomised Controlled Trial Comparing Two Different Knee Exercise Programmes in the management of Adolescents with Symptomatic Joint Hypermobility

ACTRN12606000109505Unknown
Funding Awards (26)

Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia

BioMarin Pharmaceutical · 2024

Breadth and visibility of children’s lower limb chronic musculoskeletal pain: a scoping review

Medical Research Future Fund · 2024(MRF2015863)

Variability of joint hypermobility in children: a meta-analytic approach to set cut-off scores

Monash University · 2024

Pediatric joint hypermobility: a diagnostic framework and narrative review

Ehlers-Danlos Society · 2023

Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial

BioMarin Pharmaceutical · 2023

Australian guidelines for the management of children with achondroplasia

Macquarie University · 2023

AB1783-HPR VALIDATION OF AN ELECTRONIC VISUAL ANALOG SCALE APP FOR PAIN EVALUATION IN CHILDREN AND ADOLESCENTS WITH SYMPTOMATIC HYPERMOBILITY: CROSS-SECTIONAL STUDY

Eli Lilly and Company · 2023

AB1783-HPR VALIDATION OF AN ELECTRONIC VISUAL ANALOG SCALE APP FOR PAIN EVALUATION IN CHILDREN AND ADOLESCENTS WITH SYMPTOMATIC HYPERMOBILITY: CROSS-SECTIONAL STUDY

Pfizer · 2023

AB1783-HPR VALIDATION OF AN ELECTRONIC VISUAL ANALOG SCALE APP FOR PAIN EVALUATION IN CHILDREN AND ADOLESCENTS WITH SYMPTOMATIC HYPERMOBILITY: CROSS-SECTIONAL STUDY

Gilead Sciences · 2023

Lifetime impact of achondroplasia: Current evidence and perspectives on the natural history

Osteogenesis Imperfecta Foundation · 2021

Identifiers & Metadata
Profile ID:A5073832418
ORCID:0000-0002-3961-0493
Confidence:HIGH
Collaborators:2
Verification:Round 2 CONFIRMED: database and ORCID records both perfectly match the name 'Louise Tofts'. database shows 55 works and multiple Australian affiliations (e.g., The University of Sydney, Children's Hospital at Westmead).
Publications (52 shown of 55 total)

Generalized Joint Hypermobility in Adults: A Systematic Review With Meta‐Analysis to Identify Data‐Driven Cut‐offs Using the Beighton Score

Arthritis Care & Research · 2025 · 0 citations● Rehab-relevant

Websites parents' access for information regarding their child's chronic lower limb pain: A qualitative study

Patient Education and Counseling · 2025 · 0 citations● Rehab-relevant

Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia

Children · 2024 · 13 citations

Variability of joint hypermobility in children: a meta-analytic approach to set cut-off scores

European Journal of Pediatrics · 2024 · 8 citations● Rehab-relevant

Breadth and visibility of children’s lower limb chronic musculoskeletal pain: a scoping review

BMJ Open · 2024 · 4 citations● Rehab-relevant

P139: Persistent growth-promoting effects of vosoritide in children with achondroplasia for up to 4 years: Update from phase 3 extension study*

Genetics in Medicine Open · 2024 · 2 citations

P131: Persistence of growth-promoting effects in infants and toddlers with achondroplasia: Results from a phase II extension study with vosoritide*

Genetics in Medicine Open · 2024 · 1 citations

P141: Persistent growth-promoting effects of vosoritide in children with achondroplasia is accompanied by improvement in physical aspects of quality of life*

Genetics in Medicine Open · 2024 · 1 citations● Rehab-relevant

Contributors

Elsevier eBooks · 2024 · 0 citations

Widespread pain in childhood

Elsevier eBooks · 2024 · 0 citations● Rehab-relevant